Trial
NCT05571267
Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
IVERIC bio, Inc.
Collaborators
—
Condition
Neovascular Age-Related Macular Degeneration
Intervention
Avacincaptad Pegol
Why stopped
Following Sponsor reassessment, OPH2004 enrollment was stopped to initiate a new Zimura wet AMD trial, OPH2007, for treatment-naïve patients. Thus, only one patient was enrolled into and completed Study OPH2004.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-13